Topically administered infliximab can work in ulcerative proctitis despite the ineffectiveness of intravenous induction therapy

Am J Gastroenterol. 2009 Jul;104(7):1857-8. doi: 10.1038/ajg.2009.147. Epub 2009 May 12.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Rectal
  • Adult
  • Anti-Inflammatory Agents / administration & dosage*
  • Antibodies, Monoclonal / administration & dosage*
  • Colonoscopy / methods
  • Female
  • Follow-Up Studies
  • Humans
  • Infliximab
  • Infusions, Intravenous
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / pathology
  • Proctocolitis / diagnosis*
  • Proctocolitis / drug therapy*
  • Proctoscopy / methods
  • Remission Induction
  • Retreatment
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Failure
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab